Lanthanum carbonate (Prasco Laboratories)


Welcome to the PulseAid listing for the Lanthanum carbonate drug offered from Prasco Laboratories. This Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Prasco Laboratories
NON-PROPRIETARY NAME: LANTHANUM CARBONATE
SUBSTANCE NAME: LANTHANUM CARBONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Phosphate Binder [EPC],Phosphate Chelating Activity [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, CHEWABLE
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2017-08-30
END MARKETING DATE: 0000-00-00


Lanthanum carbonate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLanthanum carbonate from Prasco Laboratories
LABELER NAME: Prasco Laboratories
DEA SCHEDULE:
ACTIVE STRENGTH: 500(mg/1)
START MARKETING DATE: 2017-08-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 66993-422_7f2a2f9a-86e3-4a11-81c8-11a3bf88bbe9
PRODUCT NDC: 66993-422
APPLICATION NUMBER: NDA021468

Other LANTHANUM CARBONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Avera McKennan HospitalFosrenol
Cardinal HealthFosrenol
Lupin Pharmaceuticals, Inc.Lanthanum Carbonate
Prasco LaboratoriesLanthanum carbonate
Shire US Manufacturing Inc.Fosrenol